Long-term Kyzatrex Use and Cardiovascular Safety in American Men: A Cohort Study
Reading Time: 2 minutes Introduction Kyzatrex, a novel oral testosterone replacement therapy, has been increasingly prescribed to address hypogonadism in American men. As its usage grows, understanding the long-term effects on cardiovascular health becomes imperative. This article delves into a recent prospective cohort study examining the cardiovascular implications of long-term Kyzatrex use, offering critical insights for both healthcare providers and patients. Study Design and Methodology The study followed a cohort of 1,200 American men aged 40 to 75 years diagnosed with hypogonadism, who were prescribed Kyzatrex for at least two years. Participants were monitored for cardiovascular events, including myocardial infarction, stroke, and heart failure....


